The 'Ozempic effect' is weighing on gym stocks. But it could turn out to be a boom for the industry

An analyst says the "gut reaction" that Ozempic and other GLP-1 medications are bad for gyms appears to be "increasingly falling by the wayside."

Related Keywords

United States ,America ,Jeff Zwiefel ,Chris Rondeau ,Piper Sandler ,Bahram Akradi ,Korinne Wolfmeyer ,Curtis Harman ,Alexander Perry ,Novo Nordisk Ozempic ,Warren Cheng ,Simeon Siegel ,Health Wellness ,Lifetime Holdings ,Planet Fitness ,Life Time ,Consumer Softlines ,Wall Street ,Time President ,Chief Operating Officer Jeff Zwiefel ,Novo Nordisk ,Harman Fitness ,Novo Nordiska S ,Life Time Group Holdings Inc ,Planet Fitness Inc ,Markets ,Investment Strategy ,Business News ,